Session Details
[1-MO10]JSNM Oral 10:Drug Discovery and development 3:PET
Thu. Nov 19, 2026 2:10 PM - 3:00 PM JST
Thu. Nov 19, 2026 5:10 AM - 6:00 AM UTC
Thu. Nov 19, 2026 5:10 AM - 6:00 AM UTC
Room 9（4F Medium Conference Room 401+402+403）
Chair: Yoichi Shimizu (Kyoto University Hospital, Kyoto University), Takeshi Fuchigami (Graduate School of Engineering, Kyoto University)
[1-MO10-01]Preclinical validation of a new fatty acid binding protein 3 ligand [18F]LUF
Jun Toyohara1, Muneyuki Sakata1, Tetsuro Tago1, Taichi Komoda2, Masahiko Ito2, Hiroshi Yoshino2 (1.Research Team for Neuroimaging, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan, 2.R&D Center, Shiratori Pharmaceuticals Co., Ltd., Narashino, Japan)
[1-MO10-02]Developing two 64Cu-labelled cyclic peptides targeting uPAR
Kazui Nakamoto, Lin Xie, Masayuki Hanyu, Yiding Zhang, Tomomi Kokufuta, Takayuki Ohkubo, Ayumi Kadoma, Hidekatsu Wakizaka, Kotaro Nagatsu, Tatsuya Kikuchi, Ming-Rong Zhang (Department of Advanced Nuclear Medicine Sciences, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan)
[1-MO10-03]Synthesis and biological evaluation of [11C]OCS5 for clinical studies
Chie Suzuki1, Tomomi Shinke2, Masami Futatsubashi2, Kengo Sato2, Yuji Matsumoto2, Kazuya Omura2, Masakatsu Kanazawa3, Yasuomi Ouchi1,2, Akira Makino1, Hidenori Yamasue4, Yasuhiro Magata1 (1.Institute of Photonics Medicine, Hamamatsu University School of Medicine, 2.Hamamatsu Medical Photonics Foundation, Hamamatsu, Japan, 3.Hamamatsu Photonics K. K., Hamamatsu, Japan, 4.Department of Psychiatry, Hamamatsu University School of Medicine, Hamamatsu, Japan)
[1-MO10-04]Evaluation of 89Zr-Labeled Datopotamab for PET Imaging of In Vivo TROP2 Expression
Nao Kobayashi1, Yoichi Shimizu2, Daisuke Okajima3, Yuji Nakamoto1 (1.Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine Kyoto University, Kyoto, Japan, 2.Department of Radiology, Kyoto University Hospital, Kyoto, Japan, 3.Discovery Research Laboratories, Daiichi Sankyo Co.,Ltd.,Tokyo, Japan)
[1-MO10-05]Development of PET tracers for imaging ApoE-binding plaques in Alzheimer’s disease
Ryuichi Harada1,2, Rumi Nakayama-naono1, Takayuki Sakai2, Shozo Furumoto2, Nobuyuki Okamura1,2 (1.Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan, 2.Research Center for Accelerator and Radioisotope Science, Tohoku University)